Dr. Greg Marchand Named to the Fulbright Specialist Roster by the U.S. Department of State
FOR IMMEDIATE RELEASE
MESA, Ariz. — May 20, 2019
The Marchand Institute is honored to present two papers at this year’s Annual SLS Meeting in New Orleans, Louisiana on September 4th – 7th 2019.
In addition, the Marchand Institute for Minimally Invasive Surgery is recognized as the featured fellowship for the conference, with a full page in the meeting’s brochure. The full brochure is available at: https://sls.org/wp-content/uploads/2019/05/SLSNow-Q2-2019.pdf
Our two papers involve single-port hysterectomy and two port trachelectomy. We look forward to seeing many of our friends and colleagues at the meeting and gala in New Orleans!
About Dr. Greg Marchand
Greg J. Marchand, MD, FACS, FACOG, FICS, is a dual board-certified obstetrician-gynecologist and minimally invasive gynecologic surgeon practising in Mesa, Arizona. He holds the ABOG Focused Practice Designation in Minimally Invasive Gynecologic Surgery and directs the Marchand Institute for Minimally Invasive Surgery, a 501(c)(3) tax-exempt non-profit research and educational corporation (EIN 42-2857240). He is Program Director of an SLS-accredited fellowship in Minimally Invasive and Robotic Gynecologic Surgery, holds three issued United States patents, and has served as Principal Investigator on eight FDA clinical trials. His systematic reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised with the Cochrane Risk of Bias 2 tool. He accepts no industry funding for his research.
Media Contact
Maria A. Sainz
Director of Communications and Media Relations
maria@marchandobgyn.com
(480) 999-0905
Newsroom and press kit · Full publication list · Research methodology · Expert commentary topics
###
Related posts
